Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H19N3O5S |
Molecular Weight | 461.49 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(C(=O)NC2=CC=CC=N2)=C(OC(=O)\C=C\C3=CC=CC=C3)C4=C(C=CC=C4)S1(=O)=O
InChI
InChIKey=GPUVGQIASQNZET-CCEZHUSRSA-N
InChI=1S/C24H19N3O5S/c1-27-22(24(29)26-20-13-7-8-16-25-20)23(18-11-5-6-12-19(18)33(27,30)31)32-21(28)15-14-17-9-3-2-4-10-17/h2-16H,1H3,(H,25,26,29)/b15-14+
Molecular Formula | C24H19N3O5S |
Molecular Weight | 461.49 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Piroxicam cinnamate (Cinnoxicam) is the anti-inflammatory agent. It is a cyclooxygenase inhibitor. Cinnoxicam was used in patients with inflammatory-degenerative osteoarticular diseases. The treatment brought about a significant improvement in the clinical variables considered (spontaneous pain at rest and on movement and functional limitation), which was observed within a few days of starting therapy. Tolerance was good, only a few slight side-effects having been reported. Cinnoxicam is a safe and reliable therapeutic option for men with oligoasthenospermia associated with a grade III varicocele, but surgery is better for those with grade II, IV and V. Piroxicam cinnamate as a long-acting prodrug is marketed by SPA in Italy for the treatment of rheumatic disorders.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Clinical pharmacology of non-steroidal anti-inflammatory drugs. A new benzothiazine derivative: cinnoxicam]. | 1988 Sep |
|
[Analgesic activity of cinnoxicam. Findings of clinical sensimetry]. | 1989 Dec 15 |
|
[Combined clinico-thermographic findings for the evaluation of a topical anti-inflammatory agent. Study of cinnoxicam cream]. | 1991 Jul-Aug |
|
[Correlation of the lipophilicity of the active agents with their topical anti-inflammatory activity]. | 1992 Jul-Aug |
|
Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. | 1994 Feb |
|
Contact allergy to cinnoxicam. | 1995 Jan |
|
[In vitro effects of L-carnitine on the inhibition of sperm mobility induced by FANS]. | 2000 May-Jun |
|
Medical therapy of oligoasthenospermia associated with left varicocele. | 2003 Apr |
|
Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. | 2004 Sep-Oct |
|
Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex. | 2007 Aug |
|
Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. | 2012 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:49:14 GMT 2023
by
admin
on
Fri Dec 15 15:49:14 GMT 2023
|
Record UNII |
7E8Q32N75N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1323
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
87234-24-0
Created by
admin on Fri Dec 15 15:49:14 GMT 2023 , Edited by admin on Fri Dec 15 15:49:14 GMT 2023
|
PRIMARY | |||
|
SUB14900MIG
Created by
admin on Fri Dec 15 15:49:14 GMT 2023 , Edited by admin on Fri Dec 15 15:49:14 GMT 2023
|
PRIMARY | |||
|
33787
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID10236212
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
m8889
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
W-149
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106889
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
C057291
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
C73032
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
655
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
7E8Q32N75N
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
100000079144
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY | |||
|
6436090
Created by
admin on Fri Dec 15 15:49:15 GMT 2023 , Edited by admin on Fri Dec 15 15:49:15 GMT 2023
|
PRIMARY |